Results 111 to 120 of about 400,942 (132)

Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics.

J Lab Physicians, 2016
Dey B, Badhe B, Govindarajan KK, Ramesh RA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma.

Clinical Genitourinary Cancer, 2022
BACKGROUND Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) is a unique subtype with poor prognosis, its response to systemic therapy is not fully understood, we evaluated the benefit of systemic therapy in these patients.
Xie-Qiao Yan, Li Zhou, Siming Li, Xiao-Wen Wu, C. Cui, Z. Chi, L. Si, Y. Kong, B. Tang, Caili Li, L. Mao, Xuan Wang, B. Lian, Xue Bai, Jie Dai, Jun Guo, X. Sheng   +16 more
semanticscholar   +1 more source

Renal cancer associated with Xp11.2 translocation/TFE3 gene fusion: Clinicopathological analysis of 13 cases.

Annals of Diagnostic Pathology, 2022
OBJECTIVE To explore the clinicopathological characteristics, immunohistochemical phenotype, diagnosis and differential diagnosis of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
R. Feng, Y. Tao, Yuangui Chen, Wen-Kai Xu, Gui-Yun Zhang, Haifeng Wang   +5 more
semanticscholar   +1 more source

Unravelling the mysteries of Xp11.2 translocation‐associated renal cell carcinoma: A case report with a review of the literature

Cytopathology, 2023
Cytomorphologic and immunocytochemical features of TFE3 translocation-associated renal cell carcinoma.
Rachagiri Suneel, Parikshaa Gupta, A. Sekar, N. Gupta, A. Saxena   +4 more
semanticscholar   +1 more source

Clinical features and therapeutic experiences of renal cancer related to Xp11.2 translocation/TFE3 gene fusion: A case series of 18 patients.

Pathology, Research and Practice
BACKGROUND This study aims to summarize the clinical features, imaging characteristics, and treatment outcomes of Xp11.2 translocation/TFE3 gene fusion-associated renal cell carcinoma (Xp11.2 tRCC), a rare and distinct subtype of kidney cancer ...
Ze-Hua Shu, Yang Lv, Mi-Mi Zhao, Xinyi Liu, Qiang Ma, Siming Fu, Gao-Lei Liu, Weihua Lan, Yao Zhang   +8 more
semanticscholar   +1 more source

Xp11.2 translocation renal cell carcinoma with osseous metaplasia

Journal of Clinical Urology, 2021
Xp11.2 translocation renal cell carcinoma is an uncommon and distinctive subtype of renal neoplasm. Osseous metaplasia with renal cell carcinoma is extremely rare and only less than 20 cases have been reported in the literature distinctly in clear cell ...
Mfundiso Zondo, A. M. Mukendi, Faizel Dhoodhat, N. Mtshali, P. Mosiane   +4 more
semanticscholar   +1 more source

Contrast-Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma

Journal of Ultrasound in Medicine, 2022
Weidong Gan, Fan Zhang, Yanwen Lu
exaly  

Up-regulation of mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma

Cancer Letters, 2022
Weidong Gan, Lei Yang, Ning Liu
exaly  

Xp11.2 translocation renal cell carcinoma with osseous metaplasia

Journal of Clinical Urology, 2022
Alain Mwamba Mukendi
exaly